B3GAT1 and glioblastoma: Upon coincubation of CAR T cells with patient-derived GBM-SCs, we consistently observed an upregulation of CD57 [6], a terminally sulfated carbohydrate epitope best known as a marker for terminally differentiated, end-stage T cells [12,13].